Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lucas, A. M.
Right arrow Articles by Cohen, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lucas, A. M.
Right arrow Articles by Cohen, S. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETAMINOPHEN
Medline Plus Health Information
*Kidney Diseases
*Liver Diseases
*Pain Relievers
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Ribose Cysteine Protects Against Acetaminophen-Induced Hepatic and Renal Toxicity

Angela M. Lucas

Department of Pharmaceutical Sciences, Toxicology Program, University of Connecticut, Storrs, Connecticut 06269-2092

Gayle Hennig

Department of Pathobiology, Toxicology Program, University of Connecticut, Storrs, Connecticut 06269-3089

Pamela K. Dominick

Department of Medicinal Chemistry, University of Utah, Salt Lake City, Utah 84112

Herbert E. Whiteley

Department of Pathobiology, Toxicology Program, University of Connecticut, Storrs, Connecticut 06269-3089

Jeanette C. Roberts

Department of Medicinal Chemistry, University of Utah, Salt Lake City, Utah 84112

Steven D. Cohen

Department of Pharmaceutical Sciences, Toxicology Program, University of Connecticut, Storrs, Connecticut 06269-2092

Ribose cysteine (RibCys) is a cysteine prodrug that increases both hepatic and renal glutathione with documented antagonism of acetaminophen (APAP)-induced hepatotoxicity. To determine if RibCys could also protect against APAP-induced kidney damage, mice were injected with APAP (600 mg/kg) or APAP and RibCys (1.0 g/kg) (APAP/RIB) followed by additional RibCys injections 1 and 2 hours later. Mice were euthanatized 10-12 hours after APAP administration, and liver and kidney toxicity were assessed by plasma sorbitol dehydrogenase (SDH) activity and blood urea nitrogen (BUN), respectively, and by histopathology. APAP treatment resulted in elevation of SDH activity and BUN to 2,490 U/ml and 47 mg/dl, respectively. By contrast, SDH and BUN values for APAP/RIB-treated mice were not different from controls, 0 U/ml and 31 mg/dl, respectively. Histopathologic examination revealed moderate to severe hepatic centrilobular necrosis in 9/11 and renal proximal tubular necrosis in 10/11 APAP-treated mice. However, no evidence of hepatic or renal toxicity was noted in any of the 12 APAP/RIB-treated mice. Utilizing the same treatment regimen, APAP covalent binding to hepatic and renal cytosolic proteins was assessed 4 hours after APAP challenge. RibCys cotreatment decreased covalent binding to the 58-kDa acetaminophen-binding protein in both liver and kidney. RibCys decreased both toxicity and covalent binding after APAP administration, and in addition to protecting the liver, this cysteine prodrug can also effectively protect the kidney from APAP-induced injury.

Key Words: Paracetamol • 4-hydroxy-acetanilide • RibCys • 2(R,S)-D-ribo-(1',2',3',4'-tetrahydroxybutyl)thiazolidine-4(R)-carboxylic acid • liver • kidney • antidote

References

  • Bartolone JB, Birge RB, Sparks K., Cohen SD, Khairallah EA (1988). Immunochemical analysis of acetaminophen covalent binding to proteins. Partial characterization of the major acetaminophen-binding liver proteins. Biochem Pharmacol 37: 4763-4774.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Beierschmitt WP, Brady JT, Bartolone JB, Wyand DS, Khairallah EA, Cohen SD (1989). Selective protein arylation and the age dependency of acetaminophen hepatotoxicity in mice. Toxicol Appl Pharmacol 98: 517-529.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Birge RB, Bartolone JB, Hart SG, Nishanian EV, Tyson CA, Khairallah EA, Cohen SD (1990). Acetaminophen hepatotoxicity: Correspondence of selective protein arylation in human and mouse liver in vitro, in culture, and in vivo. Toxicol Appl Pharmacol 105: 472-482.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bjorck S., Svalander CT, Aurell M. (1988). Acute renal failure after analgesic drugs including paracetamol (acetaminophen). Nephron 49: 45-53.[Web of Science][Medline] [Order article via Infotrieve]
  • Blakely P. (1995). Acute renal failure due to acetaminophen ingestion: A case report and review of the literature. J Am Soc Nephrol 6: 48-53.[Abstract]
  • Boyd EM, Bereczky GM (1966). Liver necrosis from paracetamol. Br J Pharmacol 26: 606-614.
  • Boyer TD, Rouff SL (1971). Acetaminophen-induced hepatic necrosis and renal failure. JAMA 218: 440-441.[Abstract/Free Full Text]
  • Butterworth M. (1992). Cysteine isopropylester protects against paracetamol-induced toxicity. Biochem Pharmacol 43: 483-488.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Chan Tyk, Chan Ayw, Critchley Jajh (1993). Paracetamol poisoning and hepatotoxicity in Chinese—The Prince of Wales Hospital (Hong Kong) experience. Singapore Med J 34: 299-302.[Medline] [Order article via Infotrieve]
  • Clissold SP (1986). Paracetamol and phenacetin. Drugs 32(suppl 4): 46-59.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cobden I., Record CO, Ward MK, Kerr Dns (1982). Paracetamol-induced acute renal failure in the absence of fulminant liver damage. Br Med J 284: 21-22.[Free Full Text]
  • Cohen SD, Hoivik DJ, Khairallah EA (1998). Acetaminophen-induced hepatotoxicity. In: Toxicology of the Liver, 2nd ed, Plaa GL, and Hewitt WR (eds). Raven Press, New York, pp 159-186.
  • Cohen SD, Khairallah EA (1997). Selective protein arylation and acetaminophen-induced hepatotoxicity. Drug Metab Rev 29: 59-77 [published erratum, 29: 1285].[Web of Science][Medline] [Order article via Infotrieve]
  • Cohen SD, Pumford NR, Khairallah EA, Boekelheide K., Pohl LR, Amouzadeh HR, Hinson JA (1997). Selective protein covalent binding and target organ toxicity. Toxicol Appl Pharmacol 143: 1-12.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Corcoran GB, Racz WJ, Smith CV, Mitchell JR (1985). Effects of N-acetylcysteine on acetaminophen covalent binding and hepatic necrosis in mice. J Pharmacol Exp Ther 232: 864-872.[Abstract/Free Full Text]
  • Davenport A., Finn R. (1988). Paracetamol (acetaminophen) poisoning resulting in acute renal failure without hepatic coma. Nephron 50: 55-56.[Web of Science][Medline] [Order article via Infotrieve]
  • Davidson DG, Eastham WN (1966). Acute liver necrosis following overdose of paracetamol. Br Med J 2: 497-499.[Free Full Text]
  • Emeigh Hart S., Beierschmitt WP, Bartolone JB, Wyand DS, Khairallah EA, Cohen SD (1991). Evidence against deacetylation and for cytochrome P450-mediated activation in acetaminophen-induced nephrotoxicity in the CD-1 mouse. Toxicol Appl Pharmacol 107: 1-15.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Emeigh Hart S., Beierschmitt WP, Wyand DS, Khairallah EA, Cohen SD (1994). Acetaminophen nephrotoxicity in CD-1 mice. I. Evidence of a role for in situ activation in selective covalent binding and toxicity. Toxicol Appl Pharmacol 126: 267-275.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Flanagan RJ, Meredith TJ (1991). Use of N-acetylcysteine in clinical toxicology. Am J Med 91: 131S-139S.[Medline] [Order article via Infotrieve]
  • Gabriel R. (1982). Paracetamol-induced acute renal failure in the absence of fulminant liver damage. Br Med J 284: 505-506.[Free Full Text]
  • Gerlach U., Hiby W. ( 1971). Sorbitol dehydrogenase. In: Methods of Enzymatic Analysis, 2nd ed, Bergmeyer HU (ed). Verlag Chemie, Weinheim, Germany, pp 567-573.
  • Gervais R., Lussier-Labelle F., Beaudet P. (1984). Anaphlylactoid reaction to acetylcysteine. Clin Pharm 3: 586-587.[Web of Science][Medline] [Order article via Infotrieve]
  • Hamlyn AN (1978). Paracetamol poisoning [letter]. Br Med J 2: 1089.[Free Full Text]
  • Hoivik DJ, Fisher RL, Brendel K., Gandolfi AJ, Khairallah EA, Cohen SD (1996). Protein arylation precedes acetaminophen toxicity in a dynamic organ slice culture of mouse kidney. Fundam Appl Toxicol 34: 99-104.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hoivik DJ, Manautou JE, Best W., Polsky SL, Emeigh Hart S., Khairallah EA, Cohen SD (1996). Nephrotoxicity with absence of hepatotoxicity in CD-1 mice given acetaminophen (APAP) and N-acetylcysteine (NAC). Toxicologist 30: 281.
  • Hoivik DJ, Manautou JE, Tveit A., Hart SG, Khairallah EA, Cohen SD (1995). Gender-related differences in susceptibility to acetaminophen-induced protein arylation and nephrotoxicity in the CD-1 mouse. Toxicol Appl Pharmacol 130: 257-271.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hoivik DJ, Manautou JE, Tveit A., Mankowski DC, Khairallah EA, Cohen SD (1996). Evidence suggesting the 58-kDa acetaminophen binding protein is a preferential target for acetaminophen electrophile. Fundam Appl Toxicol 32: 79-86.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR, Brodie BB (1973). Acetaminophen-induced necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther 187: 195-202.[Abstract/Free Full Text]
  • Kleinman JG, Breitenfield RV, Roth DA ( 1980). Acute renal failure associated with acetaminophen ingestion: Report of a case and review of the literature. Clin Nephrol 14: 201-205.[Web of Science][Medline] [Order article via Infotrieve]
  • Knoop KJ, Snook CP, Stephan M., Wason S. (1993). Failure of N-acetylcysteine (NAC) to prevent acetaminophen-induced renal failure. Vet Hum Toxicol 35: 336-336.
  • Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.[CrossRef][Medline] [Order article via Infotrieve]
  • Lanfear J., Fleming J., Walker M., Harrison P. (1993). Different patterns of regulation of the genes encoding the closely related 56 kDa selenium- and acetaminophen-binding proteins in normal tissues and during carcinogenesis. Carcinogenesis 14: 335-340.[Abstract/Free Full Text]
  • Larsen LC, Fuller S. (1996). Management of acetaminophen toxicity. Am Fam Physician 53: 185-190.[Web of Science][Medline] [Order article via Infotrieve]
  • Litovitz TL, Felberg L., White S., Klein-Schwartz W. (1998). 1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 14: 435-487.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275.[Free Full Text]
  • Makin AJ, Wendon J., Williams R. (1995). A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology 109: 1907-1916.
  • Manautou JE, Hoivik DJ, Tveit A., Hart SG, Khairallah EA, Cohen SD (1994). Clofibrate pretreatment diminishes acetaminophen's selective covalent binding and hepatotoxicity. Toxicol Appl Pharmacol 129: 252-263.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • McClain CJ, Holtzman JL, Allen J., Kromhout J., Shedlofsky S. (1988). Clinical features of acetaminophen toxicity. J Clin Gastroenterol 10: 76-80.[Web of Science][Medline] [Order article via Infotrieve]
  • McLean AE, Day PA ( 1975). The effect of diet on the toxicity of paracetamol and the safety of paracetamol-methionine mixtures. Biochem Pharmacol 24: 37-42.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Meredith TJ, Crome P., Volans G., Goulding R. (1978). Treatment of paracetamol poisoning [letter]. Br Med J 293: 345-346.
  • Mitchell JR, Jollow DJ, Potter WZ, Davis DC, Gillette JR, Brodie BB (1973). Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 187: 185-194.[Abstract/Free Full Text]
  • Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB (1973). Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 187: 211-217.[Abstract/Free Full Text]
  • Placke ME, Ginsberg GL, Wyand DS, Cohen SD (1987). Ultrastructural changes during acute acetaminophen-induced hepatotoxicity in the mouse: A time and dose study. Toxicol Pathol 15: 431-438.[Web of Science][Medline] [Order article via Infotrieve]
  • Placke ME, Wyand DS, Cohen SD (1987). Extrahepatic lesions induced by acetaminophen in the mouse. Toxicol Pathol 15: 381-387.[Web of Science][Medline] [Order article via Infotrieve]
  • Roberts JC, Charyulu RL, Zera RT, Nagasawa HT (1992). Protection against acetaminophen hepatotoxicity by ribose-cysteine (RibCys). Pharmacol Toxicol 70: 281-285.[Web of Science][Medline] [Order article via Infotrieve]
  • Roberts JC, Francetic DJ (1991). Time course for the elevation of glutathione in numerous organs of L1210-bearing CDF1 mice given the L-cysteine prodrug, RibCys. Toxicol Lett 59: 245-251.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Roberts JC, Koch KE, Detrick SR, Warters RL, Lubec G. (1995). Thiazolidine prodrugs of cysteamine and cysteine as radioprotective agents. Radiat Res 143: 203-213.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Roberts JC, Nagasawa HT, Zera RT, Fricke RF, Goon DJ ( 1987). Prodrugs of L-cysteine as protective agents against acetaminophen-induced hepatotoxicity. 2-(Polyhydroxyalkyl)- and 2-(polyacetoxyalkyl)thiazolidine-4(R)-carboxylic acids. J Med Chem 30: 1891-1896.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rumack BH, Peterson RC, Koch GG, Amara IA (1981). Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med 141: 380-385.[Abstract/Free Full Text]
  • Smilkstein MJ, Douglas DR, Daya MR (1994). Acetaminophen poisoning and liver function. N Engl J Med 331: 1310-1311.[Free Full Text]
  • Towbin H., Staehelin T., Gordon J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354.[Abstract/Free Full Text]
  • Vale JA, Meredith TJ, Goulding R. (1981). Treatment of acetaminophen poisoning. The use of oral methionine. Arch Intern Med 141: 394-396.[Abstract/Free Full Text]
  • Walton NG, Mann TA, Shaw KM ( 1979). Anaphylactoid reaction to N-acetylcysteine. Lancet ii: 1298.
  • Wilkinson R., James OF, Roberts SH, Morley AR, Robson V. (1979). Plasma renin activity during the development of paracetamol (acetaminophen) induced acute renal failure in man. Clin Nephrol 11: 196-201.[Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 28, No. 5, 697-704 (2000)
DOI: 10.1177/019262330002800510


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. V. Terneus, K. K. Kiningham, A. B. Carpenter, S. B. Sullivan, and M. A. Valentovic
Comparison of S-Adenosyl-L-methionine and N-Acetylcysteine Protective Effects on Acetaminophen Hepatic Toxicity
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 99 - 107.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
G. Dai, L. He, N. Chou, and Y.-J. Y. Wan
Acetaminophen Metabolism Does Not Contribute to Gender Difference in Its Hepatotoxicity in Mouse
Toxicol. Sci., July 1, 2006; 92(1): 33 - 41.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Dai, N. Chou, L. He, M. A. Gyamfi, A. J. Mendy, A. L. Slitt, C. D. Klaassen, and Y.-J. Y. Wan
Retinoid X Receptor {alpha} Regulates the Expression of Glutathione S-transferase Genes and Modulates Acetaminophen-Glutathione Conjugation in Mouse Liver
Mol. Pharmacol., December 1, 2005; 68(6): 1590 - 1596.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lucas, A. M.
Right arrow Articles by Cohen, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lucas, A. M.
Right arrow Articles by Cohen, S. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETAMINOPHEN
Medline Plus Health Information
*Kidney Diseases
*Liver Diseases
*Pain Relievers
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?